Meet Our Experts Please select a topic: Chemistry, Manufacturing and Control AuditBiopharmaceuticalsCell LinesCMO & CRO Selection and ManagementDue DiligenceFormulation DevelopmentGMPInterim ManagementIn Vitro DiagnosticsIVDLife-cycle ManagementProgram & Project EvaluationQualified PersonQuality Control and AssuranceR&D StrategiesRadiopharmaceuticalsRegulatory CMCRisk ManagementScientific Writing Non-clinical Research and Development Contract Research ServiceDisease ModelsDrug DiscoveryDue DiligenceGrant ApplicationImaging Agents & MethodologyInterim ManagementOncologyPharmacodynamicsPharmacokineticsPharmacologyPreclinical DevelopmentR&D StrategiesREACHScientific MarketingScientific WritingTarget IdentificationTest Laboratory ServiceToxicology Clinical Development BiomarkersBiostatisticsBusiness DevelopmentClinical Development Phase IClinical Development Phase II-IIIDrug SafetyDue DiligenceIn Vitro DiagnosticsIVDHealth Economics and Market AccessImagingLicensingInterim ManagementKnowledge ManagementLife-cycle ManagementMedical AffairsMedical DevicesPharmacogeneticsPK-PDR&D StrategiesSubmission SupportTranslational Medicine Regulatory Affairs and Compliance Conformity AssessmentCTAsDrug SafetyDue DiligenceIn Vitro DiagnosticsIVDGxPsLife-cycle ManagementMedical DevicesPharmacovigilanceQuality AssuranceQuality SystemsRegulatory AffairsRegulatory StrategiesScientific Advice ProceduresSOPsSubmissions Business Strategy & Development, Intellectual Property and Corporate Design Agreements & ContractsBusiness DevelopmentBusiness RepresentationCommercial StrategyCommercial OperationsCommunicationCorporate DesignCorporate FinanceFunding OpportunitiesGeneral ManagementIntellectual PropertyInterim ManagementLawLicensingM&AsMarket ResearchMarketingSalesSocial MediaTrademarks Sanna-Maria Käkönen Non-clinical Development (oncology), Scientific Marketing, Scientific Writing Astrid Schott Clinical Development, Interim Management, R&D Strategies Mark Waring Drug Safety, Pharmacovigilance Wolfgang M. Roßberg Toxicology, Medical Writing, Non-clinical Development, R&D Strategies Johannes Lampe Clinical Development, R&D Strategies Wolf-Stefan Richter Clinical Development, R&D Strategies Carsten Schwenke Statistics Sebastian Tegethoff Law Christian Nagelstrasser Corporate Design Michael Zimmermann Medical Devices – Clinical and Regulatory Affairs Heiner Zindel CMC Jens Hoffmann Preclinical Development, R&D Strategies Jörg Täubel Clinical Pharmacology Cardiac Safety Expert Jürgen Conrad Public Funding of R&D Moritz Hillgenberg Commercial Assessment, Market Research Michael Hildebrand CMC, Preclinical Development Siglinde Dürr Quality Management, Auditing, CMC Matthias Bräutigam Preclinical Development, R&D Strategies Christian Wolf Clinical Development, Interim Management, Medical Affairs Thomas Fink Corporate Finance Daniel Sehrt Clinical Development, R&D Strategies Frank S. Zollmann Clinical Development, Preclinical Development, R&D Strategies Hans Hendriks Pre- and Early Clinical Development, R&D Strategies, Scientific and Medical Writing Nicola Henneberg-Busse Business Development, Partnering & Licensing, Business Plans Pascal Piller Preclinical Development, REACH, Regulatory Affairs, Test Laboratory Service Anke Maaßen In Vitro Diagnostics – RA, QM, QA, CMC